| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Associated with SF3B1-mutated MDS and poorer overall survival; potential biomarker of mutational signature and patient outcome. |
| Molecular mechanism: |
circZEB1 expression is associated with mutant SF3B1 and presumed alterations in splicing behavior; functional impact was not experimentally assessed. |
| Biological pathway or process: |
other pathway/process (other) |
| Detected method: |
S
|
| Validation methods: |
RNA-seq; Clinical Sample Validation; Cohort Study; Survival Analysis; Bioinformatics Analysis |
| Clinical significance: |
High circZEB1 levels in SF3B1-mutated MDS were associated with poorer overall survival at 5 years. |
| Description: |
circZEB1 (hsa_circ_0000228) is upregulated in MDS, particularly in cases with SF3B1 mutations. In the independent ring sideroblast cohort, high circZEB1 expression among SF3B1-mutated patients was associated with poorer overall survival, suggesting clinical biomarker potential rather than a mechanistically validated functional role. |
| Confidence score: |
0.5121 |